NCT05698160View on ClinicalTrials.gov

Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Blood Coagulation Disorder
All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

NCT05698160 - Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction | Biotech Hunter | Biotech Hunter